MedTrace Logo

Stop Vasodepressor Drugs in Reflex Syncope

NCT02137278 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2015-12-29

No results posted yet for this study

Summary

Investigate clinical effects (reduction of number of syncope and associate symptoms) of suspension of vasoactive drugs in patients affected by vasodepressor reflex syncope.

Conditions

  • Hypotensive Syncope

Interventions

DRUG

Vasoactive drug therapies

Continue current vasoactive therapy

OTHER

Stop/reduce vasoactive drugs

Discontinuation of any vasoactive therapy or reduction of vasoactive drug therapies as much as possible according to clinical judgment.

Sponsors & Collaborators

  • Gruppo Italiano Multidisciplinare per lo Studio della Sincope

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137278 on ClinicalTrials.gov